Aarti Industries Ltd · NSE:AARTIIND
Aarti Industries — Q4 FY26 Earnings Presentation
22 slides from Aarti Industries's earnings presentation, May 4, 2026
Slide 1: Exchange filing cover letter: Results Presentation
May 04, 2026 To, To, Listing/Compliance Department Listing/Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra-Kurla Complex, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. BSE CODE : 524208
Slide 2: Q4 FY26 Performance Update
A Legacy of Q4 FY26 Excellence Performance Update A Future of 4 May, 2026 Possibilities
Slide 3: Disclaimer
Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does not
Slide 4: Index
Company overview Index Q4 FY26 Highlights Future Outlook and Roadmap
Slide 5: Index
Company overview Index Q4 FY26 Highlights Future Outlook and Roadmap
Slide 6: Aarti Industries at a Glance
Aarti Industries at a Glance Established by first generation technocrats in 1984 Benzene based Feedstock Assurance and Downstream Products Supply Integrated operations and high-cost optimization Toluene based Technology Sharing Key value chains include Nitro Chloro Benzenes, Downstream Products Spec
Slide 7: Our Ethos
Our Ethos AIL VALUES PURPOSE Right Chemistry for a Brighter Tomorrow VISION To emerge as a Global Partner of Choice for leading consumers of speciality chemicals and intermediates MISSION Delighted Stakeholders CARE INTEGRITY EXCELLENCE 6
Slide 8: Index
Company overview Index Q4 FY26 Highlights Future Outlook and Roadmap
Slide 9: Business Highlights FY26
Business Highlights FY26 Navigating a roller coaster year Sustainability ● DJSI | Achieved a 2025 CSA score of 78 (last year 62) | Top 2% (500+ global chemical companies) ● AIL featured in the S&P Global Sustainability Yearbook 2026 Partnerships ● Existing Long Term contracts progressing well and re
Slide 10: Q4 & FY26 Highlights (Consolidated)
Q4 & FY26 Highlights (Consolidated) ₹ in Cr YoY: 9%▲ QoQ:3%▼ YoY: 30%▲ QoQ: 6%▲ YoY: 43%▲ QoQ: 3%▲ Revenue increased due to: Volumes increased across various products such as MMA, NT, DCB, MEA China Anti-involution supporting margin upticks in products such as PNCB Business Volumes (Q4) Energy Non-E
Slide 11: Capacities and utilization trend for few major products
Capacities and utilization trend for few major products Capacity FY25 Q4 FY25 Q3 FY26 Q4 FY26 Y-o-Y Y-o-Y FY26 Product Groups FY26 (kT) Q-o-Q (in KTPA) (kT) (kT) (kT) (kT) Q4 Yearly Utilization% NCB 108 85.3 23.9 24.6 24.8 92.7 1% 4% 9% 86% DCB 120 88.6 20.4 25.9 29.3 96.5 13% 44% 9% 80% Hydrogenati
Slide 12: Revenue by End Use
Revenue by End Use ₹ Cr 8046 1867 2250 2492 2422 9018 18% 12% Agrochemicals application showing steady Agrochemicals & 19% 19% 18% 18% volume growth; margins continue to remain Fertilizers under pressure. 11% 12% 15% 11% 10% 11% Dyes, Pigment & Printing Inks applications Dyes, Pigments and operating
Slide 13: Application wise market updates & business highlights (1/2)
Application wise market updates & business highlights (1/2) End Use Agrochemical & Fertilizers Energy & Additives Chloro Anilines, Di Chloro Phenols, Ethylated & Key Products MMA, CaCl2 Fluorinated products Revenue Share 19% 42% Domestic / Exports Domestic Export Domestic Export 44% 56% 29% 71% • Gr
Slide 14: Application wise market updates & business highlights (2/2)
Application wise market updates & business highlights (2/2) Dyes, Pigments & Printing End Use Pharmaceuticals Polymer and additives Inks PNCB, MDCB & Fluorinated Key Products NCBs, DCBH, PNT PDCB, MPDA, ONA compounds Revenue Share 10% 10% 14% Domestic Export Domestic Export Domestic Export Domestic/
Slide 15: Joint Ventures
Joint Ventures DCA downstream JV with Superform Project progressing well as planned. About 70% of the targeted amount has been invested. Tailwinds in one of the end applications being witnessed; may support quicker capacity utilization Expected commissioning in H1FY27 Chemical Recycling of plastics
Slide 16: Aarti Industries wins GEWA Award
EXCEPTIONAL AARTI INDUSTRIES WORKPLACE AWARD WINS GEWA AWARD 15
Slide 17: Index
Company overview Index Q4 FY26 Highlights Future Outlook and Roadmap
Slide 18: Key EBITDA Growth Drivers in near term (FY26 - FY28)
Key EBITDA Growth Drivers in near term (FY26 - FY28) Cost Optimisation Volume and margin ramp-up CAPEX-led growth ₹ 150-200 crore ₹ 350-550 crore ₹ 300-450 crore Switching to Back Pressure Turbine to Acid, DCB & NCB value chain Pilot commissioned to fuel New improve Cogen ramp-up Product Development
Slide 19: Long term growth focus areas
Long term growth focus areas MPP and Zone 4 Commercialization • R&D and MPP will support quick development, qualification and commercialization of new advanced chemistries • Chlorotoluene commissioning and ramp up will open up new opportunities in Agro and Pharma business segments New Growth Avenues
Slide 20: Growth Outlook
Growth Outlook EBITDA, ₹ Cr Consistent volume growth over 3 yrs driven 1800 - 2200 by increased capacities, despite margin pressures Operating leverages and cost optimisation initiatives to drive EBITDA growth beyond volume growth Capex for FY26 at about ₹1125 Cr. Zone IV projects delayed by 3-4 mon
Slide 21: Certifications
wr w f Certifications QU ssires ] ro ees “S re) ecovadis i SUSTAINABILITY Is errmeteetn NA Sw Responsible Care® CORES ISO 45001:2018 1s0_14001
Slide 22: Thank You
investorrelations@aarti-industries.com Thank You